共 77 条
[1]
Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries CA Cancer J Clin 71 209-249
[2]
Ferlay J(2022)Integrated proteogenomic characterization of urothelial carcinoma of the bladder J Hematol Oncol 15 76-439
[3]
Siegel RL(2019)Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer Trends Cancer 5 426-2810
[4]
Xu N(2016)Bladder cancer Lancet 388 2796-5381
[5]
Yao Z(2018)National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging Cancer Med 7 5370-137
[6]
Shang G(2014)Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review Eur Urol 66 120-4345
[7]
Ghandour R(2020)Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer Curr Treat Options Oncol 22 3-487
[8]
Singla N(2020)Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions Curr Oncol Rep 22 14-10
[9]
Lotan Y(2017)Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer Cancer 123 4337-188
[10]
Kamat AM(2017)Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder Eur Urol 72 483-41